Furthermore, these findings were supported when the expression of Plk1 and Plk4 was analyzed in publicly available databases, as the expression of Plk1 and Plk4 was found to be significantly higher in B-ALL patients compared to sorted normal B-cells from healthy donors. The gene discussed is PLK4; the disease is precursor B-cell acute lymphoblastic leukemia.